RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jaguar Health Stock

Jaguar Health Net Income 2024

Jaguar Health Net Income

-7.35 M USD

Ticker

JAGX

ISIN

US47010C4096

WKN

A2PLYX

In 2024, Jaguar Health's profit amounted to -7.35 M USD, a -82.2% increase from the -41.3 M USD profit recorded in the previous year.

The Jaguar Health Net Income history

YEARNET INCOME (undefined USD)
2028e-
2027e-
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-

Jaguar Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Jaguar Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Jaguar Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Jaguar Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Jaguar Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Jaguar Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Jaguar Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Jaguar Health’s growth potential.

Jaguar Health Revenue, EBIT and net profit per share

DateJaguar Health RevenueJaguar Health EBITJaguar Health Net Income
2028e389.44 M undefined0 undefined0 undefined
2027e204 M undefined105.67 M undefined0 undefined
2026e26.74 M undefined45.19 M undefined-16.87 M undefined
2025e18.55 M undefined-21.85 M undefined-24.6 M undefined
2024e12.92 M undefined-28.17 M undefined-7.35 M undefined
20239.76 M undefined-33.92 M undefined-41.3 M undefined
202211.96 M undefined-34.42 M undefined-47.45 M undefined
20214.34 M undefined-39.07 M undefined-52.6 M undefined
20209.39 M undefined-21.3 M undefined-38.65 M undefined
20195.78 M undefined-24.3 M undefined-44.73 M undefined
20184.42 M undefined-25.61 M undefined-32.15 M undefined
20174.36 M undefined-15.12 M undefined-21.97 M undefined
2016142,000 undefined-13.59 M undefined-14.73 M undefined
2015258,000 undefined-12.45 M undefined-16.64 M undefined
20140 undefined-7.9 M undefined-9.26 M undefined
20130 undefined-778,000 undefined-801,000 undefined

Jaguar Health stock margins

The Jaguar Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Jaguar Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Jaguar Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Jaguar Health's sales revenue. A higher gross margin percentage indicates that the Jaguar Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Jaguar Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Jaguar Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Jaguar Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Jaguar Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Jaguar Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Jaguar Health Margin History

Jaguar Health Gross marginJaguar Health Profit marginJaguar Health EBIT marginJaguar Health Profit margin
2028e79.13 %0 %0 %
2027e79.13 %51.8 %0 %
2026e79.13 %169 %-63.1 %
2025e79.13 %-117.76 %-132.59 %
2024e79.13 %-218.1 %-56.91 %
202379.13 %-347.51 %-423.11 %
202283.11 %-287.85 %-396.91 %
202146.18 %-901.36 %-1,213.26 %
202065.05 %-227 %-411.81 %
201933.92 %-420.76 %-774.48 %
201837.36 %-580 %-727.94 %
201779.82 %-346.71 %-503.76 %
201663.38 %-9,567.61 %-10,376.06 %
201552.33 %-4,823.64 %-6,448.84 %
201479.13 %0 %0 %
201379.13 %0 %0 %

Jaguar Health Aktienanalyse

What does Jaguar Health do?

Jaguar Health Inc. is a biopharmaceutical company based in San Francisco, California, focused on the development and commercialization of innovative plant-based medicines. The company's history dates back to the founding of Napo Pharmaceuticals in 2002, which was renamed Jaguar Animal Health in 2007 to focus on the development of animal medicines. In 2015, Jaguar Health then established a subsidiary named Napo Pharmaceuticals to focus on the development of plant-based medicines for human use. Jaguar Health's business model is based on the research and development of medicines derived from plant extracts, particularly from the rainforest region in South America. The company collaborates with local communities and government agencies to ensure sustainable use of these plant resources. An important aspect of the business model is also cooperation and partnership with other companies and organizations to accelerate research and development and facilitate the market launch of new medicines. Jaguar Health is divided into different divisions that focus on specific medical applications. One important division is HIV/AIDS research, where the company is investigating various plant extracts that can alleviate symptoms of the disease and inhibit the spread of the virus. Another division is oncology research, in which Jaguar Health is working on the development of plant-based compounds that can inhibit the growth of tumor cells and improve the quality of life for cancer patients. A particular focus of Jaguar Health is also the research of plant-based medicines for the treatment of gastrointestinal diseases. The company has already developed the drug Mytesi based on the Croton lechleri tree, which is used to treat diarrhea in HIV/AIDS patients. Mytesi was approved by the US Food and Drug Administration (FDA) in 2016 and is the first drug developed by the company to market. Other products and medicines that Jaguar Health is working on include the drug Canalevia for the treatment of gastrointestinal inflammation in dogs and cats, as well as the drug Neonorm, which aims to improve intestinal mobility in foals and other animal species. Overall, Jaguar Health is working on a wide range of plant-based medicines and compounds for the treatment of various diseases and ailments. The company relies on close collaboration with government agencies, local communities, and other companies to accelerate the development and commercialization of innovative medicines while ensuring sustainable use of natural resources. Jaguar Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Jaguar Health's Profit Margins

The profit margins of Jaguar Health represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Jaguar Health's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Jaguar Health's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Jaguar Health's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Jaguar Health’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Jaguar Health stock

How much profit has Jaguar Health made this year?

Jaguar Health has made -7.35 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -82.2% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Jaguar Health publish its earnings?

Jaguar Health publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Jaguar Health?

The profits of Jaguar Health are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Jaguar Health?

You can learn more about the earnings of Jaguar Health by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Jaguar Health pay?

Over the past 12 months, Jaguar Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jaguar Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Jaguar Health?

The current dividend yield of Jaguar Health is .

When does Jaguar Health pay dividends?

Jaguar Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Jaguar Health?

Jaguar Health paid dividends every year for the past 0 years.

What is the dividend of Jaguar Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Jaguar Health located?

Jaguar Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jaguar Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jaguar Health from 10/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2024.

When did Jaguar Health pay the last dividend?

The last dividend was paid out on 10/8/2024.

What was the dividend of Jaguar Health in the year 2023?

In the year 2023, Jaguar Health distributed 0 USD as dividends.

In which currency does Jaguar Health pay out the dividend?

The dividends of Jaguar Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Jaguar Health stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Jaguar Health

Our stock analysis for Jaguar Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jaguar Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.